Singapore-based biotechnology startup Mirxes has received $40 million in structured financing from CBC Group’s R-Bridge Healthcare Fund (R-Bridge) to support its growth and expansion into key global markets, according to an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
